PE20160191A1 - Cepa de lactobacillus como probiotico - Google Patents
Cepa de lactobacillus como probioticoInfo
- Publication number
- PE20160191A1 PE20160191A1 PE2016000240A PE2016000240A PE20160191A1 PE 20160191 A1 PE20160191 A1 PE 20160191A1 PE 2016000240 A PE2016000240 A PE 2016000240A PE 2016000240 A PE2016000240 A PE 2016000240A PE 20160191 A1 PE20160191 A1 PE 20160191A1
- Authority
- PE
- Peru
- Prior art keywords
- strain
- candidiasis
- ability
- treatment
- bacterial vaginosis
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title abstract 2
- 235000018291 probiotics Nutrition 0.000 title abstract 2
- 241000186660 Lactobacillus Species 0.000 title 1
- 229940039696 lactobacillus Drugs 0.000 title 1
- 230000000529 probiotic effect Effects 0.000 title 1
- 206010007134 Candida infections Diseases 0.000 abstract 4
- 201000003984 candidiasis Diseases 0.000 abstract 4
- 241000222122 Candida albicans Species 0.000 abstract 3
- 208000004926 Bacterial Vaginosis Diseases 0.000 abstract 2
- 208000037009 Vaginitis bacterial Diseases 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- 240000002355 Celtis tournefortii var. glabrata Species 0.000 abstract 1
- 241000186684 Lactobacillus pentosus Species 0.000 abstract 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 abstract 1
- 239000003429 antifungal agent Substances 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 229940095731 candida albicans Drugs 0.000 abstract 1
- 238000011260 co-administration Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/36—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
Abstract
Se proporciona la nueva cepa de Lactobacillus pentosus CECT 7504. La cepa presenta como principales ventajas una alta supervivencia a factores antimicrobianos del fluido vaginal, que a menudo se incrementan en un subconjunto de pacientes con candidiasis, y que podrian ser muy perjudiciales para muchos probioticos; la capacidad para inhibir Candida albicans y C. glabrata, mostrando asi un espectro de actividad mas amplio para tratar las infecciones por Candida tales como la candidiasis vulvovaginal ; la capacidad de sobrevivir en altas concentraciones de agentes antimicoticos usados tipicamente para el tratamiento de infecciones por Candida, permitiendo asi su co-administracion; y una capacidad mejorada para acidificar el fluido vaginal, mostrando asi un gran potencial para tratar la vaginosis bacteriana. Asi, la cepa y los productos que la comprenden son utiles en la prevencion y/o tratamiento de la candidiasis (oral, intestinal y vaginal) y de la vaginosis bacteriana
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13382326 | 2013-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20160191A1 true PE20160191A1 (es) | 2016-04-15 |
Family
ID=49029045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2016000240A PE20160191A1 (es) | 2013-08-12 | 2014-08-11 | Cepa de lactobacillus como probiotico |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US10149872B2 (es) |
| EP (1) | EP3035943B1 (es) |
| JP (1) | JP6587614B2 (es) |
| KR (1) | KR102146146B1 (es) |
| CN (1) | CN105555284B (es) |
| AU (1) | AU2014307938B2 (es) |
| BR (1) | BR112016002888B1 (es) |
| CA (1) | CA2920819C (es) |
| EA (1) | EA030595B1 (es) |
| ES (1) | ES2742410T3 (es) |
| MX (1) | MX368473B (es) |
| MY (1) | MY171618A (es) |
| PE (1) | PE20160191A1 (es) |
| PH (1) | PH12016500304B1 (es) |
| PL (1) | PL3035943T3 (es) |
| PT (1) | PT3035943T (es) |
| TW (1) | TWI643626B (es) |
| WO (1) | WO2015022297A1 (es) |
| ZA (1) | ZA201601119B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12060599B2 (en) | 2015-09-09 | 2024-08-13 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis |
| BE1023643B1 (nl) * | 2016-03-21 | 2017-06-01 | Yun NV | Vaginale preparaten voor het onderhouden en / of herstellen van een gezonde vrouwelijke microbiota |
| BE1024425B9 (nl) * | 2016-06-21 | 2018-03-26 | Yun NV | Dermatologische preparaten voor het onderhouden en/of herstellen van een gezonde huidmicrobiota |
| CN106520600A (zh) * | 2016-10-25 | 2017-03-22 | 天益健康科学研究院（镇江）有限公司 | 一种低pH条件下抑菌复合微生物制剂 |
| US20190339269A1 (en) * | 2017-01-03 | 2019-11-07 | The Trustees Of The University Of Pennsylvania | Compositions and methods for predicting risk of preterm birth |
| US11138746B2 (en) | 2017-07-03 | 2021-10-05 | Ricoh Company, Ltd. | Diagnostic support system and diagnostic support method |
| PL233261B1 (pl) * | 2017-08-21 | 2019-09-30 | Politechnika Lodzka | Szczep bakterii mlekowych Lactobacillus pentosus |
| CN109662259B (zh) * | 2017-10-16 | 2022-07-29 | 江苏省农业科学院 | 一种富益生菌冻干毛豆粒产品及其制备方法 |
| CN109864270B (zh) * | 2017-12-01 | 2022-07-29 | 江苏省农业科学院 | 一种富益生菌冻干胡萝卜丁产品及其制备方法 |
| JP2020075921A (ja) * | 2018-11-02 | 2020-05-21 | ロート製薬株式会社 | 膣用固形医薬組成物 |
| FR3089788B1 (fr) * | 2018-12-17 | 2020-12-18 | Lesaffre & Cie | Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées |
| IT201900000801A1 (it) * | 2019-01-18 | 2020-07-18 | Proge Farm Srl | Composizione comprendente batteri probiotici non vitali e suo uso in terapia |
| KR102244492B1 (ko) * | 2020-10-21 | 2021-04-26 | 대한민국(관리부서:국립수산과학원) | 신규 락토바실러스 속 균주 및 그의 용도 |
| KR102739246B1 (ko) * | 2022-02-11 | 2024-12-06 | 주식회사 잇츠한불 | 락토바실러스 균주 혼합물을 유효성분으로 포함하는 피부 보호용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002113041A (ja) * | 2000-10-11 | 2002-04-16 | Uni Charm Corp | 皮膚常在菌をコントロールする吸収性物品 |
| GB0124580D0 (en) * | 2001-10-12 | 2001-12-05 | Univ Reading | New composition |
| AU2003220603A1 (en) | 2002-03-28 | 2003-10-13 | Transact Technologies Incorporated | Methods and apparatus for creating customized messages for printing on a transaction slip |
| SE528382C2 (sv) * | 2004-10-05 | 2006-10-31 | Probi Ab | Probiotiska lactobacillusstammar för förbättrad vaginal hälsa |
| JP5199551B2 (ja) * | 2006-07-06 | 2013-05-15 | サンスター株式会社 | カンジダ菌感染に基づく疾患の予防又は改善剤 |
| IT1397566B1 (it) * | 2009-05-27 | 2013-01-16 | Probiotical Spa | Lactobacillus pentosus produttore di batteriocine, composizioni alimentari e farmaceutiche contenenti lo stesso e relativo uso |
| IT1403661B1 (it) * | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
-
2014
- 2014-08-08 TW TW103127325A patent/TWI643626B/zh active
- 2014-08-11 PL PL14757862T patent/PL3035943T3/pl unknown
- 2014-08-11 JP JP2016533902A patent/JP6587614B2/ja active Active
- 2014-08-11 MX MX2016001764A patent/MX368473B/es active IP Right Grant
- 2014-08-11 WO PCT/EP2014/067177 patent/WO2015022297A1/en not_active Ceased
- 2014-08-11 PE PE2016000240A patent/PE20160191A1/es unknown
- 2014-08-11 US US14/911,730 patent/US10149872B2/en active Active
- 2014-08-11 KR KR1020167006568A patent/KR102146146B1/ko active Active
- 2014-08-11 EP EP14757862.9A patent/EP3035943B1/en active Active
- 2014-08-11 PH PH1/2016/500304A patent/PH12016500304B1/en unknown
- 2014-08-11 BR BR112016002888-0A patent/BR112016002888B1/pt active IP Right Grant
- 2014-08-11 PT PT14757862T patent/PT3035943T/pt unknown
- 2014-08-11 MY MYPI2016700464A patent/MY171618A/en unknown
- 2014-08-11 AU AU2014307938A patent/AU2014307938B2/en active Active
- 2014-08-11 ES ES14757862T patent/ES2742410T3/es active Active
- 2014-08-11 EA EA201690218A patent/EA030595B1/ru not_active IP Right Cessation
- 2014-08-11 CA CA2920819A patent/CA2920819C/en active Active
- 2014-08-11 CN CN201480050874.6A patent/CN105555284B/zh active Active
-
2016
- 2016-02-18 ZA ZA2016/01119A patent/ZA201601119B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2920819A1 (en) | 2015-02-19 |
| TWI643626B (zh) | 2018-12-11 |
| KR102146146B1 (ko) | 2020-08-20 |
| EP3035943B1 (en) | 2019-05-15 |
| EP3035943A1 (en) | 2016-06-29 |
| CN105555284B (zh) | 2019-11-05 |
| JP2016533744A (ja) | 2016-11-04 |
| KR20160046834A (ko) | 2016-04-29 |
| ZA201601119B (en) | 2017-04-26 |
| CA2920819C (en) | 2020-03-24 |
| MX2016001764A (es) | 2016-07-26 |
| JP6587614B2 (ja) | 2019-10-09 |
| PH12016500304A1 (en) | 2016-05-02 |
| BR112016002888A2 (pt) | 2017-11-21 |
| AU2014307938A1 (en) | 2016-03-10 |
| PL3035943T3 (pl) | 2019-10-31 |
| PT3035943T (pt) | 2019-09-04 |
| PH12016500304B1 (en) | 2023-12-06 |
| US20160193260A1 (en) | 2016-07-07 |
| US10149872B2 (en) | 2018-12-11 |
| WO2015022297A1 (en) | 2015-02-19 |
| ES2742410T3 (es) | 2020-02-14 |
| MY171618A (en) | 2019-10-21 |
| TW201534313A (zh) | 2015-09-16 |
| CN105555284A (zh) | 2016-05-04 |
| BR112016002888B1 (pt) | 2021-12-14 |
| MX368473B (es) | 2019-10-04 |
| AU2014307938B2 (en) | 2017-08-31 |
| EA030595B1 (ru) | 2018-08-31 |
| EA201690218A1 (ru) | 2016-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20160191A1 (es) | Cepa de lactobacillus como probiotico | |
| SV2017005461A (es) | Benzamidas sustituidas con 1,3-tiazol-2-ilo | |
| ES2573524T3 (es) | Nuevo principio activo anti-enrojecimiento y composiciones cosméticas que lo comprenden | |
| CO2018005198A2 (es) | Composición que comprende una cepa bacteriana del género eubacterium | |
| CO2018005217A2 (es) | Composición que comprende una cepa bacteriana del género enterococcus gallinarum | |
| CO2018005226A2 (es) | Composición que comprende una cepa bacteriana del género erysipelatoclostridium | |
| PE20180673A1 (es) | Tratamiento contra el cancer por manipulacion de la microflora comensal | |
| MX392085B (es) | Novedosos lactobacillus que tienen diversas funciones, y uso de los mismos. | |
| AR102973A1 (es) | Uso del compuesto 3,5-dihidroxi-4-isopropil-trans-estilbeno para la preparación de una composición farmacéutica, dicho compuesto y composición farmacéutica que lo comprende | |
| MX394441B (es) | Una formulación a base de besifloxacina para usarse en el tratamiento del acné resistente a fármacos | |
| PE20181345A1 (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento del cancer | |
| ECSP18071568A (es) | Agente microbiano de suministro directo para la prevención de una patología del camarón | |
| MX2018007933A (es) | Metodo de tratamiento de mamifero, incluido el ser humano, contra cancer usando agotamiento de metionina y asparagina. | |
| CL2017001025A1 (es) | Compuestos para usarse en el tratamiento antihelmíntico | |
| MX2022014792A (es) | Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican. | |
| CL2018001936A1 (es) | Nueva cepa bacteriana probiótica de lactobacillus plantarum y composiciones y usos de la misma en el tratamiento de la inflamación. | |
| MX2016015437A (es) | Combinacion que comprende un glucocorticoide y edo-s101. | |
| CL2017000178A1 (es) | Compuestos para usar en el tratamiento antihelmíntico | |
| MX2018001720A (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos. | |
| MX380518B (es) | Reutilizacion de agente cloroso activado para el tratamiento de carne y aves. | |
| MX387476B (es) | Antibióticos de amplio espectro macrocíclico. | |
| DOP2017000014A (es) | Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo | |
| MX2017001566A (es) | Terapias antibioticas peptidicas derivadas del bufalo de agua. | |
| CL2017001818A1 (es) | Bacteria de ácido láctico y su uso para el tratamiento de mastitis | |
| CU24650B1 (es) | Combinaciones que incluyen abx196 útiles en el tratamiento del cáncer |